INTERCEPT PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Intercept Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2023.
  • Intercept Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2023 was 41.8M shares, a 0.95% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 41.8M +395K +0.95% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 41.8M +12M +40.2% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 41.7M +12M +40.3% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 41.5M +12M +40.4% Dec 31, 2022 10-Q 2023-11-06
Q3 2022 41.4M +11.9M +40.2% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 29.8M -3.4M -10.3% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 29.7M -3.45M -10.4% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 29.6M -3.44M -10.4% Dec 31, 2021 10-K 2023-03-02
Q3 2021 29.5M -3.45M -10.4% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 33.2M +220K +0.67% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 33.2M +217K +0.66% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 33M +163K +0.5% Dec 31, 2020 10-K 2022-03-02
Q3 2020 33M +259K +0.79% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 33M +284K +0.87% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 32.9M +3.16M +10.6% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 32.9M +3.16M +10.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 32.7M +3.08M +10.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 32.7M +3.13M +10.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 29.8M +4.45M +17.5% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 29.7M +4.52M +18% Dec 31, 2018 10-K 2020-02-25
Q3 2018 29.7M +4.55M +18.1% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 29.6M +4.46M +17.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 25.3M +320K +1.28% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 25.2M +353K +1.42% Dec 31, 2017 10-K 2019-03-01
Q3 2017 25.1M +311K +1.26% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 25.1M +424K +1.72% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 25M +418K +1.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 24.8M +428K +1.76% Dec 31, 2016 10-K 2018-02-28
Q3 2016 24.8M +536K +2.21% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 24.7M +527K +2.18% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 24.6M +1.89M +8.31% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 24.4M +2.98M +13.9% Dec 31, 2015 10-K 2017-03-01
Q3 2015 24.3M +2.93M +13.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 24.1M +2.97M +14% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 22.7M +3.14M +16% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 21.4M +2.03M +10.4% Dec 31, 2014 10-K 2016-02-29
Q3 2014 21.3M +2.02M +10.5% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 21.2M +2.14M +11.2% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 19.6M +2.93M +17.6% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 19.4M +2.86M +17.3% Dec 31, 2013 10-K 2015-03-02
Q3 2013 19.3M +16M +480% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 19M Jun 30, 2013 10-Q 2013-08-13
Q1 2013 16.6M Mar 31, 2013 10-Q 2013-05-14
Q4 2012 16.5M +13.2M +396% Dec 31, 2012 10-Q 2013-11-14
Q3 2012 3.33M Sep 30, 2012 10-Q/A 2012-12-21
Q4 2011 3.33M Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.